Janney Montgomery Scott LLC Clovis Oncology, Inc. Transaction History

Janney Montgomery Scott LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$2.7 - $4.76 $29,700 - $52,360	-11,000 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$5.02 - $7.05 $55,219 - $77,550	11,000 New	11,000 $64,000
Q1 2020 Apr 30, 2020	SELL	$3.77 - $11.0 $88,783 - $259,050	-23,550 Closed	0 $0
Q4 2019 Jan 21, 2020	SELL	$3.0 - $16.43 $121,986 - $668,076	-40,662 Reduced 63.32%	23,550 $246,000
Q3 2019 Oct 29, 2019	BUY	$3.93 - $15.35 $252,353 - $985,654	64,212 New	64,212 $252,000
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $446,809 - $655,072	-7,745 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $520,231 - $656,853	7,745	7,745 $638,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.